257 related articles for article (PubMed ID: 28635265)
1. Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction.
Heise T; Büll C; Beurskens DM; Rossing E; de Jonge MI; Adema GJ; Boltje TJ; Langereis JD
Bioconjug Chem; 2017 Jul; 28(7):1811-1815. PubMed ID: 28635265
[TBL] [Abstract][Full Text] [Related]
2. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
Birikaki L; Pradeau S; Armand S; Priem B; Márquez-Domínguez L; Reyes-Leyva J; Santos-López G; Samain E; Driguez H; Fort S
Chemistry; 2015 Jul; 21(30):10903-12. PubMed ID: 26088695
[TBL] [Abstract][Full Text] [Related]
3. Determination of viral neuraminidase specificity for membrane-bound sialic acids by cell electrophoresis.
Gimsa U; Gimsa J
Mol Membr Biol; 1997; 14(2):87-90. PubMed ID: 9253768
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract.
Ortigoza MB; Mobini CL; Rocha HL; Bartlett S; Loomis CA; Weiser JN
mBio; 2024 Feb; 15(2):e0220323. PubMed ID: 38206008
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid is cleaved from glycoconjugates at the cell surface when influenza virus neuraminidases are expressed from recombinant vaccinia viruses.
Els MC; Laver WG; Air GM
Virology; 1989 May; 170(1):346-51. PubMed ID: 2718386
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution.
Rameix-Welti MA; Munier S; Le Gal S; Cuvelier F; Agou F; Enouf V; Naffakh N; van der Werf S
Antivir Ther; 2011; 16(4):597-603. PubMed ID: 21685548
[TBL] [Abstract][Full Text] [Related]
7. A sequential bioorthogonal dual strategy: ManNAl and SiaNAl as distinct tools to unravel sialic acid metabolic pathways.
Gilormini PA; Lion C; Vicogne D; Levade T; Potelle S; Mariller C; Guérardel Y; Biot C; Foulquier F
Chem Commun (Camb); 2016 Feb; 52(11):2318-21. PubMed ID: 26727964
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Sialidase-Resistant Oligosaccharide and Antibody Glycoform Containing α2,6-Linked 3F
Lo HJ; Krasnova L; Dey S; Cheng T; Liu H; Tsai TI; Wu KB; Wu CY; Wong CH
J Am Chem Soc; 2019 Apr; 141(16):6484-6488. PubMed ID: 30969765
[TBL] [Abstract][Full Text] [Related]
9. Sialosides Containing 7-
Kooner AS; Yuan Y; Yu H; Kang H; Klenow L; Daniels R; Chen X
ACS Infect Dis; 2023 Jan; 9(1):33-41. PubMed ID: 36455156
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase.
Basak S; Tomana M; Compans RW
Virus Res; 1985 Feb; 2(1):61-8. PubMed ID: 3984493
[TBL] [Abstract][Full Text] [Related]
11. Endosialidase NF appears to bind polySia DP5 in a helical conformation.
Haselhorst T; Stummeyer K; Mühlenhoff M; Schaper W; Gerardy-Schahn R; von Itzstein M
Chembiochem; 2006 Dec; 7(12):1875-7. PubMed ID: 16991177
[No Abstract] [Full Text] [Related]
12. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.
Burmeister WP; Ruigrok RW; Cusack S
EMBO J; 1992 Jan; 11(1):49-56. PubMed ID: 1740114
[TBL] [Abstract][Full Text] [Related]
13. Human Neuraminidase Isoenzymes Show Variable Activities for 9- O-Acetyl-sialoside Substrates.
Hunter CD; Khanna N; Richards MR; Rezaei Darestani R; Zou C; Klassen JS; Cairo CW
ACS Chem Biol; 2018 Apr; 13(4):922-932. PubMed ID: 29341588
[TBL] [Abstract][Full Text] [Related]
14. Influenza B virus neuraminidase can synthesize its own inhibitor.
Burmeister WP; Henrissat B; Bosso C; Cusack S; Ruigrok RW
Structure; 1993 Sep; 1(1):19-26. PubMed ID: 8069621
[TBL] [Abstract][Full Text] [Related]
15. Human neuraminidases have reduced activity towards modified sialic acids on glycoproteins.
Hunter CD; Porter EM; Cairo CW
Carbohydr Res; 2020 Nov; 497():108139. PubMed ID: 32911203
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of sialyloligosaccharide fragments into the active site of influenza virus N9 neuraminidase.
Veluraja K; Suresh MX; Christlet TH; Rafi ZA
J Biomol Struct Dyn; 2001 Aug; 19(1):33-45. PubMed ID: 11565850
[TBL] [Abstract][Full Text] [Related]
17. The role of target membrane sialic acid residues in the fusion activity of the influenza virus: the effect of two types of ganglioside on the kinetics of membrane merging.
Ramalho-Santos J; Pedroso De Lima MC
Cell Mol Biol Lett; 2004; 9(2):337-51. PubMed ID: 15213813
[TBL] [Abstract][Full Text] [Related]
18. Photodegradation and inhibition of drug-resistant influenza virus neuraminidase using anthraquinone-sialic acid hybrids.
Aoki Y; Tanimoto S; Takahashi D; Toshima K
Chem Commun (Camb); 2013 Feb; 49(12):1169-71. PubMed ID: 23282898
[TBL] [Abstract][Full Text] [Related]
19. Target cell membrane sialic acid modulates both binding and fusion activity of influenza virus.
de Lima MC; Ramalho-Santos J; Flasher D; Slepushkin VA; Nir S; Düzgüneş N
Biochim Biophys Acta; 1995 Jun; 1236(2):323-30. PubMed ID: 7794972
[TBL] [Abstract][Full Text] [Related]
20. Engineering the Sialome.
Edgar LJ
ACS Chem Biol; 2021 Oct; 16(10):1829-1840. PubMed ID: 34590818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
